Form 4 for TMO Thermo Fisher Scientific
Accepted 2024-08-29 00:00:00 ET · period of report 2024-08-28 · accession 0001127602-24-023151 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-08-29 | 2024-08-28 | TMO | Lagarde Michel | EVP, COO | F - Tax | $613.14 | -646.45 | 17.1K | -4% | -$396.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-28 | F | D | 262.06 | $613.14 | 17,367.89 | D | — | — | |
| 2 | Common | Common Stock | 2024-08-28 | F | D | 165.36 | $613.14 | 16,983.50 | D | — | — | |
| 3 | Common | Common Stock | 2024-08-28 | F | D | 219.03 | $613.14 | 17,148.86 | D | — | — |